Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181 Y Pekarsky, U Santanam, A Cimmino, A Palamarchuk, A Efanov, ... Cancer research 66 (24), 11590-11593, 2006 | 864 | 2006 |
Chronic lymphocytic leukemia modeled in mouse by targeted miR-29 expression U Santanam, N Zanesi, A Efanov, S Costinean, A Palamarchuk, JP Hagan, ... Proceedings of the National Academy of Sciences 107 (27), 12210-12215, 2010 | 266 | 2010 |
Akt phosphorylates and regulates Pdcd4 tumor suppressor protein A Palamarchuk, A Efanov, V Maximov, RI Aqeilan, CM Croce, Y Pekarsky Cancer research 65 (24), 11282-11286, 2005 | 203 | 2005 |
Tcl1 functions as a transcriptional regulator and is directly involved in the pathogenesis of CLL Y Pekarsky, A Palamarchuk, V Maximov, A Efanov, N Nazaryan, ... Proceedings of the National Academy of Sciences 105 (50), 19643-19648, 2008 | 178 | 2008 |
13q14 deletions in CLL involve cooperating tumor suppressors A Palamarchuk, A Efanov, N Nazaryan, U Santanam, H Alder, L Rassenti, ... Blood, The Journal of the American Society of Hematology 115 (19), 3916-3922, 2010 | 126 | 2010 |
Investigation of the relationship between radiation dose and gene mutations and fusions in post-Chernobyl thyroid cancer AA Efanov, AV Brenner, TI Bogdanova, LM Kelly, P Liu, MP Little, AI Wald, ... JNCI: Journal of the National Cancer Institute 110 (4), 371-378, 2018 | 82 | 2018 |
Tcl1 interacts with Atm and enhances NF-κB activation in hematologic malignancies E Gaudio, R Spizzo, F Paduano, Z Luo, A Efanov, A Palamarchuk, ... Blood, The Journal of the American Society of Hematology 119 (1), 180-187, 2012 | 67 | 2012 |
Akt phosphorylates Tal1 oncoprotein and inhibits its repressor activity A Palamarchuk, A Efanov, V Maximov, RI Aqeilan, CM Croce, Y Pekarsky Cancer Research 65 (11), 4515-4519, 2005 | 58 | 2005 |
CD5+ CD23+ leukemic cell populations in TCL1 transgenic mice show significantly increased proliferation and Akt phosphorylation A Efanov, N Zanesi, N Nazaryan, U Santanam, A Palamarchuk, CM Croce, ... Leukemia 24 (5), 970-975, 2010 | 46 | 2010 |
Human HMGA2 protein overexpressed in mice induces precursor T-cell lymphoblastic leukemia A Efanov, N Zanesi, V Coppola, G Nuovo, B Bolon, D Wernicle-Jameson, ... Blood Cancer Journal 4 (7), e227-e227, 2014 | 23 | 2014 |
Heat shock protein 70 regulates Tcl1 expression in leukemia and lymphomas E Gaudio, F Paduano, A Ngankeu, F Lovat, M Fabbri, HL Sun, ... Blood, The Journal of the American Society of Hematology 121 (2), 351-359, 2013 | 22 | 2013 |
Tal1 transgenic expression reveals absence of B lymphocytes A Palamarchuk, N Zanesi, RI Aqeilan, A Efanov, V Maximov, U Santanam, ... Cancer research 66 (12), 6014-6017, 2006 | 11 | 2006 |
Frequency and perturbations of various peripheral blood cell populations before and after eculizumab treatment in paroxysmal nocturnal hemoglobinuria C Gurnari, AC Graham, A Efanov, S Pagliuca, J Durrani, H Awada, ... Blood Cells, Molecules, and Diseases 87, 102528, 2021 | 10 | 2021 |
Expression of the Human gdnfGene in a Drosophila melanogasterTransgenic Strain. GV Pavlova, EA Modestova, SP Vengrova, AA Efanov, NN Rybtzova, ... Doklady Biochemistry & Biophysics 376, 2001 | 6 | 2001 |
Expression of genes coding NGF and BDNF human proteins in embryos of transgenic stocks of Drosophila melanogaster GV Pavlova, AA Efanov, VN Bashkirov, EA Modestova, IB Mertsalov, ... Tsitologiia 44 (11), 1104-1108, 2002 | 1 | 2002 |
Selective Pharmacologic Inhibition of Paroxysmal Nocturnal Hemoglobinuria Clones AC Graham, A Efanov, BP Przychodzen, CM Hirsch, V Adema, V Visconte, ... Blood 132, 1303, 2018 | | 2018 |
B-CLL phenotype in E mu-miR-29 transgenic mice U Santanam, N Zanesi, A Efanov, A Palamarchuk, S Costinean, J Hagan, ... CANCER RESEARCH 70, 2010 | | 2010 |
Investigation of the Relationship Between Radiation Dose and Gene Mutations and Fusions in Post-Chernobyl Thyroid Cancer. AA Efanov, AV Brenner, TI Bogdanova, LM Kelly, P Liu, MP Little, AI Wald, ... | | |
SUPPLEMENTARY MATERIALS Investigation of the relationship between radiation dose and gene mutations and fusions in post-Chernobyl thyroid cancer AA Efanov, AV Brenner, TI Bogdanova, LM Kelly, P Liu, MP Little, AI Wald, ... | | |